This report aims to provide a comprehensive presentation of the global market for Genetic Modification Therapies Clinical Applications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Modification Therapies Clinical Applications. This report contains market size and forecasts of Genetic Modification Therapies Clinical Applications in global, including the following market information:
Global Genetic Modification Therapies Clinical Applications Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Genetic Modification Therapies Clinical Applications market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Genetically Modified Cell Therapies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Genetic Modification Therapies Clinical Applications include 4d Molecular Therapeutics LLC, Abeona Therapeutics LLC, Acer Therapeutics Inc., Allergan Plc and American Gene Technologies International Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Genetic Modification Therapies Clinical Applications companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genetic Modification Therapies Clinical Applications Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Genetic Modification Therapies Clinical Applications Market Segment Percentages, by Type, 2022 (%)
- Genetically Modified Cell Therapies
- RNA Therapies
- Gene Editing
Global Genetic Modification Therapies Clinical Applications Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Genetic Modification Therapies Clinical Applications Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Diagnostics and Testing Laboratories
- Academic and Research Organizations
- Others
Global Genetic Modification Therapies Clinical Applications Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Genetic Modification Therapies Clinical Applications Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Genetic Modification Therapies Clinical Applications revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Genetic Modification Therapies Clinical Applications revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- 4d Molecular Therapeutics LLC
- Abeona Therapeutics LLC
- Acer Therapeutics Inc.
- Allergan Plc
- American Gene Technologies International Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Genetic Modification Therapies Clinical Applications, market overview.
Chapter 2: Global Genetic Modification Therapies Clinical Applications market size in revenue.
Chapter 3: Detailed analysis of Genetic Modification Therapies Clinical Applications company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Genetic Modification Therapies Clinical Applications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Genetic Modification Therapies Clinical Applications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genetic Modification Therapies Clinical Applications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genetic Modification Therapies Clinical Applications Overall Market Size
2.1 Global Genetic Modification Therapies Clinical Applications Market Size: 2022 VS 2029
2.2 Global Genetic Modification Therapies Clinical Applications Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genetic Modification Therapies Clinical Applications Players in Global Market
3.2 Top Global Genetic Modification Therapies Clinical Applications Companies Ranked by Revenue
3.3 Global Genetic Modification Therapies Clinical Applications Revenue by Companies
3.4 Top 3 and Top 5 Genetic Modification Therapies Clinical Applications Companies in Global Market, by Revenue in 2022
3.5 Global Companies Genetic Modification Therapies Clinical Applications Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genetic Modification Therapies Clinical Applications Players in Global Market
3.6.1 List of Global Tier 1 Genetic Modification Therapies Clinical Applications Companies
3.6.2 List of Global Tier 2 and Tier 3 Genetic Modification Therapies Clinical Applications Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Genetic Modification Therapies Clinical Applications Market Size Markets, 2022 & 2029
4.1.2 Genetically Modified Cell Therapies
4.1.3 RNA Therapies
4.1.4 Gene Editing
4.2 By Type - Global Genetic Modification Therapies Clinical Applications Revenue & Forecasts
4.2.1 By Type - Global Genetic Modification Therapies Clinical Applications Revenue, 2018-2023
4.2.2 By Type - Global Genetic Modification Therapies Clinical Applications Revenue, 2024-2029
4.2.3 By Type - Global Genetic Modification Therapies Clinical Applications Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genetic Modification Therapies Clinical Applications Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Diagnostics and Testing Laboratories
5.1.4 Academic and Research Organizations
5.1.5 Others
5.2 By Application - Global Genetic Modification Therapies Clinical Applications Revenue & Forecasts
5.2.1 By Application - Global Genetic Modification Therapies Clinical Applications Revenue, 2018-2023
5.2.2 By Application - Global Genetic Modification Therapies Clinical Applications Revenue, 2024-2029
5.2.3 By Application - Global Genetic Modification Therapies Clinical Applications Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Genetic Modification Therapies Clinical Applications Market Size, 2022 & 2029
6.2 By Region - Global Genetic Modification Therapies Clinical Applications Revenue & Forecasts
6.2.1 By Region - Global Genetic Modification Therapies Clinical Applications Revenue, 2018-2023
6.2.2 By Region - Global Genetic Modification Therapies Clinical Applications Revenue, 2024-2029
6.2.3 By Region - Global Genetic Modification Therapies Clinical Applications Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Genetic Modification Therapies Clinical Applications Revenue, 2018-2029
6.3.2 US Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.3.3 Canada Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.3.4 Mexico Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Genetic Modification Therapies Clinical Applications Revenue, 2018-2029
6.4.2 Germany Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.4.3 France Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.4.4 U.K. Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.4.5 Italy Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.4.6 Russia Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.4.7 Nordic Countries Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.4.8 Benelux Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Genetic Modification Therapies Clinical Applications Revenue, 2018-2029
6.5.2 China Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.5.3 Japan Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.5.4 South Korea Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.5.5 Southeast Asia Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.5.6 India Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Genetic Modification Therapies Clinical Applications Revenue, 2018-2029
6.6.2 Brazil Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.6.3 Argentina Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genetic Modification Therapies Clinical Applications Revenue, 2018-2029
6.7.2 Turkey Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.7.3 Israel Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.7.4 Saudi Arabia Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
6.7.5 UAE Genetic Modification Therapies Clinical Applications Market Size, 2018-2029
7 Genetic Modification Therapies Clinical Applications Companies Profiles
7.1 4d Molecular Therapeutics LLC
7.1.1 4d Molecular Therapeutics LLC Company Summary
7.1.2 4d Molecular Therapeutics LLC Business Overview
7.1.3 4d Molecular Therapeutics LLC Genetic Modification Therapies Clinical Applications Major Product Offerings
7.1.4 4d Molecular Therapeutics LLC Genetic Modification Therapies Clinical Applications Revenue in Global Market (2018-2023)
7.1.5 4d Molecular Therapeutics LLC Key News & Latest Developments
7.2 Abeona Therapeutics LLC
7.2.1 Abeona Therapeutics LLC Company Summary
7.2.2 Abeona Therapeutics LLC Business Overview
7.2.3 Abeona Therapeutics LLC Genetic Modification Therapies Clinical Applications Major Product Offerings
7.2.4 Abeona Therapeutics LLC Genetic Modification Therapies Clinical Applications Revenue in Global Market (2018-2023)
7.2.5 Abeona Therapeutics LLC Key News & Latest Developments
7.3 Acer Therapeutics Inc.
7.3.1 Acer Therapeutics Inc. Company Summary
7.3.2 Acer Therapeutics Inc. Business Overview
7.3.3 Acer Therapeutics Inc. Genetic Modification Therapies Clinical Applications Major Product Offerings
7.3.4 Acer Therapeutics Inc. Genetic Modification Therapies Clinical Applications Revenue in Global Market (2018-2023)
7.3.5 Acer Therapeutics Inc. Key News & Latest Developments
7.4 Allergan Plc
7.4.1 Allergan Plc Company Summary
7.4.2 Allergan Plc Business Overview
7.4.3 Allergan Plc Genetic Modification Therapies Clinical Applications Major Product Offerings
7.4.4 Allergan Plc Genetic Modification Therapies Clinical Applications Revenue in Global Market (2018-2023)
7.4.5 Allergan Plc Key News & Latest Developments
7.5 American Gene Technologies International Inc.
7.5.1 American Gene Technologies International Inc. Company Summary
7.5.2 American Gene Technologies International Inc. Business Overview
7.5.3 American Gene Technologies International Inc. Genetic Modification Therapies Clinical Applications Major Product Offerings
7.5.4 American Gene Technologies International Inc. Genetic Modification Therapies Clinical Applications Revenue in Global Market (2018-2023)
7.5.5 American Gene Technologies International Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Genetic Modification Therapies Clinical Applications Market Opportunities & Trends in Global Market
Table 2. Genetic Modification Therapies Clinical Applications Market Drivers in Global Market
Table 3. Genetic Modification Therapies Clinical Applications Market Restraints in Global Market
Table 4. Key Players of Genetic Modification Therapies Clinical Applications in Global Market
Table 5. Top Genetic Modification Therapies Clinical Applications Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Genetic Modification Therapies Clinical Applications Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Genetic Modification Therapies Clinical Applications Revenue Share by Companies, 2018-2023
Table 8. Global Companies Genetic Modification Therapies Clinical Applications Product Type
Table 9. List of Global Tier 1 Genetic Modification Therapies Clinical Applications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genetic Modification Therapies Clinical Applications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Genetic Modification Therapies Clinical Applications Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Genetic Modification Therapies Clinical Applications Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Genetic Modification Therapies Clinical Applications Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Genetic Modification Therapies Clinical Applications Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Genetic Modification Therapies Clinical Applications Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Genetic Modification Therapies Clinical Applications Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2024-2029
Table 30. 4d Molecular Therapeutics LLC Company Summary
Table 31. 4d Molecular Therapeutics LLC Genetic Modification Therapies Clinical Applications Product Offerings
Table 32. 4d Molecular Therapeutics LLC Genetic Modification Therapies Clinical Applications Revenue (US$, Mn) & (2018-2023)
Table 33. 4d Molecular Therapeutics LLC Key News & Latest Developments
Table 34. Abeona Therapeutics LLC Company Summary
Table 35. Abeona Therapeutics LLC Genetic Modification Therapies Clinical Applications Product Offerings
Table 36. Abeona Therapeutics LLC Genetic Modification Therapies Clinical Applications Revenue (US$, Mn) & (2018-2023)
Table 37. Abeona Therapeutics LLC Key News & Latest Developments
Table 38. Acer Therapeutics Inc. Company Summary
Table 39. Acer Therapeutics Inc. Genetic Modification Therapies Clinical Applications Product Offerings
Table 40. Acer Therapeutics Inc. Genetic Modification Therapies Clinical Applications Revenue (US$, Mn) & (2018-2023)
Table 41. Acer Therapeutics Inc. Key News & Latest Developments
Table 42. Allergan Plc Company Summary
Table 43. Allergan Plc Genetic Modification Therapies Clinical Applications Product Offerings
Table 44. Allergan Plc Genetic Modification Therapies Clinical Applications Revenue (US$, Mn) & (2018-2023)
Table 45. Allergan Plc Key News & Latest Developments
Table 46. American Gene Technologies International Inc. Company Summary
Table 47. American Gene Technologies International Inc. Genetic Modification Therapies Clinical Applications Product Offerings
Table 48. American Gene Technologies International Inc. Genetic Modification Therapies Clinical Applications Revenue (US$, Mn) & (2018-2023)
Table 49. American Gene Technologies International Inc. Key News & Latest Developments
List of Figures
Figure 1. Genetic Modification Therapies Clinical Applications Segment by Type in 2022
Figure 2. Genetic Modification Therapies Clinical Applications Segment by Application in 2022
Figure 3. Global Genetic Modification Therapies Clinical Applications Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Genetic Modification Therapies Clinical Applications Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Genetic Modification Therapies Clinical Applications Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genetic Modification Therapies Clinical Applications Revenue in 2022
Figure 8. By Type - Global Genetic Modification Therapies Clinical Applications Revenue Market Share, 2018-2029
Figure 9. By Application - Global Genetic Modification Therapies Clinical Applications Revenue Market Share, 2018-2029
Figure 10. By Type - Global Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Genetic Modification Therapies Clinical Applications Revenue Market Share, 2018-2029
Figure 12. By Application - Global Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Genetic Modification Therapies Clinical Applications Revenue Market Share, 2018-2029
Figure 14. By Region - Global Genetic Modification Therapies Clinical Applications Revenue Market Share, 2018-2029
Figure 15. By Country - North America Genetic Modification Therapies Clinical Applications Revenue Market Share, 2018-2029
Figure 16. US Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Genetic Modification Therapies Clinical Applications Revenue Market Share, 2018-2029
Figure 20. Germany Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 21. France Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Genetic Modification Therapies Clinical Applications Revenue Market Share, 2018-2029
Figure 28. China Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 32. India Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Genetic Modification Therapies Clinical Applications Revenue Market Share, 2018-2029
Figure 34. Brazil Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Genetic Modification Therapies Clinical Applications Revenue Market Share, 2018-2029
Figure 37. Turkey Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Genetic Modification Therapies Clinical Applications Revenue, (US$, Mn), 2018-2029
Figure 41. 4d Molecular Therapeutics LLC Genetic Modification Therapies Clinical Applications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abeona Therapeutics LLC Genetic Modification Therapies Clinical Applications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Acer Therapeutics Inc. Genetic Modification Therapies Clinical Applications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Allergan Plc Genetic Modification Therapies Clinical Applications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. American Gene Technologies International Inc. Genetic Modification Therapies Clinical Applications Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
